Adherence to clinical practice guidelines and outcomes in diabetic patients.

OBJECTIVE To examine the level of adherence to clinical practice guidelines and its relationship to outcomes in patients with diabetes. DESIGN Retrospective cohort study. SETTING A tertiary teaching hospital in Korea. PARTICIPANTS Patients aged ≥18 years with diabetes (n = 4994) who visited the study hospital once or more during 2004. MAIN OUTCOME MEASURES The outcomes were mortality from the database of the Statistics Korea and end-stage renal disease (ESRD) incidence from ESRD registry in the Korean Society of Nephrology until December 2009. RESULTS Testing rates for blood pressure, eye examination, HbA1c, renal function and lipid profiles were 93.9, 32.8, 84.9, 33.5 and 45.9%, respectively. The percentage of patients achieving each treatment goal was 27.8% for blood pressure, 44.2% for HbA1c and 49.4% for low-density lipoprotein (LDL) cholesterol. There were 11.7% patients with composite outcome (death and/or ESRD). Male gender, level of HbA1c (<7%), presence of HbA1c data, checking eye examination, presence of data on urine albumin-to-creatinine ratio (UACR) and having anti-platelet medication were associated with better outcome. CONCLUSIONS The adherence to recommendations was unsatisfactory, especially in checking eye examination, testing UACR and LDL cholesterol, and achieving a target goal for each parameter. Guideline adherence was positively related to better prognosis. Active strategies to apply the guidelines to clinical practice should be developed to improve patient outcomes.

[1]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[2]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[3]  M. Dennis A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[4]  R. Klein Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.

[5]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[6]  K. Choi,et al.  Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. , 2006, Diabetes care.

[7]  P. Winocour Effective diabetes care: a need for realistic targets , 2002, BMJ : British Medical Journal.

[8]  K. Khunti,et al.  Quality of care of patients with diabetes: collation of data from multi-practice audits of diabetes in primary care. , 1999, Family practice.

[9]  G. Kelton,et al.  Utilization of health care quality markers in a family medicine outpatient setting. , 2006, Family medicine.

[10]  Weiping Jia,et al.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.

[11]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[12]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[13]  D. Clement A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[14]  M. Chin,et al.  Quality of diabetes care in community health centers. , 2000, American journal of public health.

[15]  Opinions of Japanese rheumatology physicians regarding clinical practice guidelines. , 2010, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[16]  G. Costa,et al.  Determinants of Quality in Diabetes Care Process , 2009, Diabetes Care.

[17]  P. Bovier,et al.  Adherence to recommended standards of diabetes care by Swiss primary care physicians. , 2007, Swiss medical weekly.

[18]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[19]  David Roth,et al.  A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .

[20]  Sarah J. Beaton,et al.  Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. , 2004, Diabetes care.